logo
Select company
Select metric
$ -39.38MOperating Income
VS
Market
19
Sector
43
Industry
58
History
79
$ 0.79Close
$ 0.58 - $ 1.87 52-Week Range
Ticker Information

Ticker

CUE

Company Name

CUE BIOPHARMA INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CUE BIOPHARMA INC - Operating Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CUE - Op. Inc. Historical data
DateOperating Income
6/30/2025$ -39.38M
3/31/2025$ -41.13M
12/31/2024$ -41.5M
9/30/2024$ -45.7M
6/30/2024$ -48.3M
3/31/2024$ -51.44M
12/31/2023$ -52.15M
9/30/2023$ -53.18M
6/30/2023$ -52.79M
3/31/2023$ -52.37M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CUE BIOPHARMA INC's latest trailing twelve months (TTM) Op. Inc. stands at $ -43.08M.
  • Over the past 5 years, CUE BIOPHARMA INC's average Op. Inc. has been $ -46.91M.
  • The median Op. Inc. for CUE BIOPHARMA INC during this period was $ -45.98M
  • CUE BIOPHARMA INC reached its highest Op. Inc. over the past 5 years at $ -39.38M.
  • The lowest Op. Inc. recorded by CUE BIOPHARMA INC in the same timeframe $ -53.22M

CUE BIOPHARMA INC's Op. Inc. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Op. Inc. Benchmarks
CompanyOp. Inc.
OVID : OVID THERAPEUTICS INC $ -41.57MVERU : VERU INC $ -34.12MPSTV : PLUS THERAPEUTICS INC $ -12.77MCRVO : CERVOMED INC $ -24.56MSRZN : SURROZEN INC $ -27.89MTCRX : TSCAN THERAPEUTICS INC $ -144.24MCBUS : CIBUS INC $ -277.98MFATE : FATE THERAPEUTICS INC $ -192.37MALGS : ALIGOS THERAPEUTICS INC $ -78.5MPYXS : PYXIS ONCOLOGY INC $ -106.49M

Definition of Operating Income

[Income Statement] Operating income (income from operations) represents the gross profit [GP] less operating expenses [OpEx]. Operating income doesn’t include interest expenses [IntExp], tax expenses [TaxExp] and other Non-Operating items.

CUE - Operating Income, Last 5 years

$ -53.22M

Minimum

Dec 31, 2022

$ -39.38M

Maximum

Jun 30, 2025

$ -46.91M

Average

$ -45.98M

Median

Op. Inc. Benchmark Analysis

The chart above depicts the distribution of Op. Inc. for companies in the Total Stock Market. The average Op. Inc. of the companies is $ 26.4M with a standard deviation of $ 130.88M.
The following table provides additional summary stats:
Op. Inc. in the Market:
filtered constituents3.31K
min$ -410.64M
max$ 444.54M
average$ 26.4M
median$ -873.07K
std$ 130.88M